HGH Fragment 176-191 Hilma Biocare

HGH Fragment 176-191 by Hilma Biocare is a modified peptide made from amino acids 176–191 of the growth hormone molecule — the portion responsible for fat metabolism. It is engineered specifically to drive fat loss while preserving lean muscle, which makes it a favourite during cutting cycles. Unlike full-length HGH, the fragment does not raise blood sugar or affect insulin sensitivity, so it targets fat reduction without the systemic effects of complete growth hormone.

Effects and benefits

The fragment stimulates lipolysis — the breakdown of stored fat — and mildly lifts metabolic rate, all while sparing muscle. Because it avoids the hyperglycemic effect of full HGH, it can be run for longer cutting blocks with a cleaner side-effect profile.

• Promotes significant fat loss
• Preserves lean muscle mass
• Increases metabolic rate
• Improves definition and vascularity

Usage and administration

The peptide is reconstituted with bacteriostatic water and dosed around 250–500 mcg per day, often split and timed to fasted cardio for maximum lipolytic effect. As a research peptide it belongs alongside the rest of the peptides range rather than in an anabolic cycle.

Stacking and combinations

For a stronger recomposition protocol, the fragment is often paired with a GH-pulse combo such as CJC-1295 DAC and Ipamorelin to amplify fat loss and recovery.

Why choose Hilma Biocare

Each vial is produced to consistent pharmaceutical standards with reliable peptide content you can trust. Explore the full Hilma Biocare catalogue to build a complete cutting stack.